Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ResMed Inc.

    NYSE: RMD · Real-Time Price · USD
    286.15
    1.26 (0.44%)
    At close: Aug 18, 2025, 3:59 PM
    291.56
    1.89%
    After-hours: Aug 18, 2025, 06:56 PM EDT
    0.44%
    Bid 284.5
    Market Cap 41.9B
    Revenue (ttm) 5.15B
    Net Income (ttm) 1.4B
    EPS (ttm) 9.52
    PE Ratio (ttm) 30.06
    Forward PE 25.9
    Analyst Buy
    Ask 291.56
    Volume 408,272
    Avg. Volume (20D) 914,545
    Open 285.23
    Previous Close 284.89
    Day's Range 284.42 - 287.83
    52-Week Range 199.92 - 293.08
    Beta 0.77

    About RMD

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol RMD
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for RMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    ResMed Inc. is scheduled to release its earnings on Oct 23, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 weeks ago
    +2.67%
    ResMed shares are trading higher after the company... Unlock content with Pro Subscription
    3 months ago
    +10.14%
    ResMed shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results. Also, Keybanc maintained an Overweight rating on the stock and raised its price target from $269 to $274.
    news image

    5 days ago · zacks.com

    Why ResMed (RMD) is a Top Momentum Stock for the Long-Term

    The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

    news image

    1 week ago · zacks.com

    Why ResMed (RMD) is a Top Growth Stock for the Long-Term

    The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

    news image

    2 weeks ago · benzinga.com

    ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings

    Resmed Inc RMD reported better-than-expected earnings for the second quarter on Thursday.

    news image

    2 weeks ago · zacks.com

    Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb

    RMD tops Q4 earnings and revenue estimates with double-digit growth, rising margins and strong global device demand.

    news image

    2 weeks ago · seekingalpha.com

    ResMed Inc. (RMD) Q4 2025 Earnings Call Transcript

    ResMed Inc. (NYSE:RMD ) Q4 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Brett A. Sandercock - Chief Financial Officer Michael J.

    news image

    2 weeks ago · zacks.com

    Here's What Key Metrics Tell Us About ResMed (RMD) Q4 Earnings

    The headline numbers for ResMed (RMD) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a...

    news image

    2 weeks ago · zacks.com

    ResMed (RMD) Surpasses Q4 Earnings and Revenue Estimates

    ResMed (RMD) came out with quarterly earnings of $2.55 per share, beating the Zacks Consensus Estimate of $2.46 per share. This compares to earnings of $2.08 per share a year ago.

    news image

    2 weeks ago · reuters.com

    Resmed beats quarterly profit estimates on strong demand for sleep devices

    Resmed beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea.

    news image

    2 weeks ago · fxempire.com

    Spot Outliers Like ResMed Early with Money Flows

    ResMed, Inc. (RMD) shares up almost 3,142% since first Big Money outlier signal in 2000.

    news image

    3 weeks ago · zacks.com

    Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?

    ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

    Add to Watchlist